Trials / Conditions / Type 1 Papillary Renal Cell Carcinoma

Type 1 Papillary Renal Cell Carcinoma

6 registered clinical trials studyying Type 1 Papillary Renal Cell Carcinoma.

Status	Trial	Sponsor	Phase
Completed	Testing Cabozantinib, Crizotinib, Savolitinib and Sunitinib in Kidney Cancer Which Has Progressed NCT02761057	National Cancer Institute (NCI)	Phase 2
Completed	Bevacizumab With or Without TRC105 in Treating Patients With Metastatic Kidney Cancer NCT01727089	National Cancer Institute (NCI)	Phase 2
Completed	Tivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Ki NCT01688973	National Cancer Institute (NCI)	Phase 2
Completed	Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Mali NCT00078858	Fred Hutchinson Cancer Center	Phase 1 / Phase 2
Completed	Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Tr NCT00027820	Fred Hutchinson Cancer Center	Phase 1 / Phase 2
Completed	Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients Wi NCT00005799	Fred Hutchinson Cancer Center	N/A